Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Mel - personal reminiscence.

Taeusch HW.

Front Pediatr. 2014 Jul 3;2:49. doi: 10.3389/fped.2014.00049. eCollection 2014. Review. No abstract available.

2.

Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.

Lopez-Rodriguez E, Cruz A, Richter RP, Taeusch HW, Pérez-Gil J.

J Biol Chem. 2013 Oct 11;288(41):29872-81. doi: 10.1074/jbc.M113.493957. Epub 2013 Aug 27.

3.

Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.

Lu KW, Taeusch HW, Clements JA.

Exp Lung Res. 2013 May-Jun;39(4-5):191-200. doi: 10.3109/01902148.2013.791893. Epub 2013 May 3.

PMID:
23638643
4.

Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

López-Rodríguez E, Ospina OL, Echaide M, Taeusch HW, Pérez-Gil J.

Biophys J. 2012 Oct 3;103(7):1451-9. doi: 10.1016/j.bpj.2012.08.024. Epub 2012 Oct 2.

5.

Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.

Lu KW, Pérez-Gil J, Echaide M, Taeusch HW.

Biochim Biophys Acta. 2011 Oct;1808(10):2366-73. doi: 10.1016/j.bbamem.2011.06.013. Epub 2011 Jun 27.

6.

Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.

Lopez-Rodriguez E, Echaide M, Cruz A, Taeusch HW, Perez-Gil J.

Biophys J. 2011 Feb 2;100(3):646-655. doi: 10.1016/j.bpj.2010.12.3715.

7.

Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan.

Iwanicki JL, Lu KW, Taeusch HW.

Exp Lung Res. 2010 Apr;36(3):167-74. doi: 10.3109/01902140903234186.

PMID:
20334607
8.

Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.

Lu KW, Taeusch HW.

Biochim Biophys Acta. 2010 Jun;1798(6):1129-34. doi: 10.1016/j.bbamem.2010.02.026. Epub 2010 Feb 25.

9.

Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.

Taeusch HW, Dybbro E, Lu KW.

Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):243-9. Epub 2007 Oct 24.

PMID:
18065212
10.
11.

Polyethylene glycol-surfactant for lavage lung injury in rats.

Dehority W, Lu KW, Clements J, Goerke J, Pittet JF, Allen L, Taeusch HW.

Pediatr Res. 2005 Nov;58(5):913-8. Epub 2005 Sep 23.

PMID:
16183815
12.

Effects of hyaluronan-fortified surfactant in ventilated premature piglets with respiratory distress.

Wang X, Sun Z, Qian L, Guo C, Yu W, Wang W, Lu KW, Taeusch HW, Sun B.

Biol Neonate. 2006;89(1):15-24. Epub 2005 Sep 8.

PMID:
16155382
13.

Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury.

Lu KW, Goerke J, Clements JA, Taeusch HW.

Pediatr Res. 2005 Aug;58(2):206-10. Epub 2005 Jul 31.

PMID:
16055934
14.

Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.

Zasadzinski JA, Alig TF, Alonso C, Bernardino de la Serna J, Perez-Gil J, Taeusch HW.

Biophys J. 2005 Sep;89(3):1621-9. Epub 2005 Jul 8.

15.

Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.

Taeusch HW, Bernardino de la Serna J, Perez-Gil J, Alonso C, Zasadzinski JA.

Biophys J. 2005 Sep;89(3):1769-79. Epub 2005 May 27.

16.

Dextran or polyethylene glycol added to curosurf for treatment of meconium lung injury in rats.

Lu KW, Robertson B, Taeusch HW.

Biol Neonate. 2005;88(1):46-53. Epub 2005 Mar 14.

PMID:
15767742
17.

Hyaluronan decreases surfactant inactivation in vitro.

Lu KW, Goerke J, Clements JA, Taeusch HW.

Pediatr Res. 2005 Feb;57(2):237-41. Epub 2004 Dec 7.

PMID:
15585679
18.

Variation in mortality and intraventricular haemorrhage in occupants of Pacific Rim nurseries.

Martinez A, Taeusch HW, Yu V, Tan KW, Yeung CY, Lu JH, Nishida H, Boo NY.

J Paediatr Child Health. 2002 Jun;38(3):235-40.

PMID:
12047689
19.

Pain during Mogen or PlastiBell circumcision.

Taeusch HW, Martinez AM, Partridge JC, Sniderman S, Armstrong-Wells J, Fuentes-Afflick E.

J Perinatol. 2002 Apr-May;22(3):214-8.

20.

Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries.

Lu KW, Taeusch HW, Robertson B, Goerke J, Clements JA.

Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1531-6.

PMID:
11704608
21.

Inactivation of pulmonary surfactant and the treatment of acute lung injuries.

Taeusch HW, Keough KM.

Pediatr Pathol Mol Med. 2001 Nov-Dec;20(6):519-36. Review.

PMID:
11699577
22.
23.

Hyperphagia in neonates withdrawing from methadone.

Martinez A, Kastner B, Taeusch HW.

Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F178-82.

24.

Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo.

Boncuk P, Kaser M, Yu Y, Taeusch HW.

Lipids. 1997 Mar;32(3):247-53. Erratum in: Lipids 1997 May;32(5):571.

PMID:
9076661
25.

Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments.

Gordon LM, Horvath S, Longo ML, Zasadzinski JA, Taeusch HW, Faull K, Leung C, Waring AJ.

Protein Sci. 1996 Aug;5(8):1662-75.

26.

Invited editorial on "Antenatal betamethasone therapy augments nitric oxide-mediated relaxation of preterm ovine pulmonary veins".

Fineman JR, Taeusch HW.

J Appl Physiol (1985). 1996 Feb;80(2):388-9. No abstract available.

PMID:
8929573
27.

Inactivation of surfactant in rat lungs.

Bruni R, Fan BR, David-Cu R, Taeusch HW, Walther FJ.

Pediatr Res. 1996 Feb;39(2):236-40.

PMID:
8825793
28.

Synthesis, secondary structure and folding of the bend region of lung surfactant protein B.

Waring AJ, Faull KF, Leung C, Chang-Chien A, Mercado P, Taeusch HW, Gordon LM.

Pept Res. 1996 Jan-Feb;9(1):28-39.

PMID:
8727481
29.

Surfactant replacement therapy for meconium aspiration syndrome.

Findlay RD, Taeusch HW, Walther FJ.

Pediatrics. 1996 Jan;97(1):48-52.

PMID:
8545223
30.

Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure.

Lopez SL, Taeusch HW, Findlay RD, Walther FJ.

Clin Pediatr (Phila). 1995 Aug;34(8):424-9.

PMID:
7586909
31.

Attitudes and behaviors of African-American and Mexican-American women delivering newborns in inner-city Los Angeles.

Gray S, Lawrence S, Arregui A, Phillips N, Bell R, Richards T, Fukushima T, Taeusch HW.

J Natl Med Assoc. 1995 May;87(5):353-8.

32.

Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants.

Findlay RD, Taeusch HW, David-Cu R, Walther FJ.

Pediatr Res. 1995 Jan;37(1):26-30.

PMID:
7700730
33.

Comparison of captive and pulsating bubble surfactometers with use of lung surfactants.

Putz G, Goerke J, Taeusch HW, Clements JA.

J Appl Physiol (1985). 1994 Apr;76(4):1425-31.

PMID:
8045815
36.

Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.

Amirkhanian JD, Bruni R, Waring AJ, Navar C, Taeusch HW.

Biochim Biophys Acta. 1993 Jul 1;1168(3):315-20.

PMID:
8323972
37.
38.

Morbidity of low-birthweight infants with intrauterine cocaine exposure.

Sehgal S, Ewing C, Waring P, Findlay R, Bean X, Taeusch HW.

J Natl Med Assoc. 1993 Jan;85(1):20-4.

39.

Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain.

Bruni R, Taeusch HW, Waring AJ.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7451-5.

40.
41.

Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C.

Amirkhanian JD, Bruni R, Waring AJ, Taeusch HW.

Biochim Biophys Acta. 1991 Jun 5;1096(4):355-60.

PMID:
2065107
42.
43.

Radiographic findings associated with surfactant treatment.

Soll RF, Horbar JD, Griscom NT, Barth RA, Lucey JF, Taeusch HW.

Am J Perinatol. 1991 Mar;8(2):114-8.

PMID:
2006936
44.

Steroids for respiratory distress syndrome--again.

Taeusch HW, Polk D.

J Pediatr. 1990 Aug;117(2 Pt 1):248-50. No abstract available.

PMID:
2380824
45.

Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years.

Ware J, Taeusch HW, Soll RF, McCormick MC.

Pediatrics. 1990 Jun;85(6):1103-7. Erratum in: Pediatrics 1991 Mar;87(3):412.

PMID:
1692612
46.
47.

Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C.

Takahashi A, Waring AJ, Amirkhanian J, Fan B, Taeusch HW.

Biochim Biophys Acta. 1990 May 1;1044(1):43-9.

PMID:
2160285
48.
49.

Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy.

Chida S, Phelps DS, Cordle C, Soll R, Floros J, Taeusch HW.

Am Rev Respir Dis. 1988 Apr;137(4):943-7.

PMID:
3355003
50.

Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein.

Jacobs KA, Phelps DS, Steinbrink R, Fisch J, Kriz R, Mitsock L, Dougherty JP, Taeusch HW, Floros J.

J Biol Chem. 1987 Jul 15;262(20):9808-11. Erratum in: J Biol Chem 1988 Jan 15;263(2):1093.

Supplemental Content

Loading ...
Support Center